Screening for Deep Vein Thrombosis in Intensive Care
Conditions: Deep Vein Thrombosis Interventions: Diagnostic Test: Ultrasound screening for lower limbs DVT; Diagnostic Test: Standard-of-care Sponsors: University Of Perugia; Azienda Ospedaliera di Perugia; Azienda Ospedaliera di Terni; Azienda Sanitaria Locale N.1 dell ' Umbria; USL Umbria 2 Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
Conditions: CVA (Cerebrovascular Accident) Interventions: Drug: alteplase or tenecteplase Sponsors: Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; Queen Mary Hospital, Hong Kong; Princess Margaret Hospital, Canada; Tuen Mun Hospital; The Queen Elizabeth Hospital; United Christian Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia
Conditions: Acute Lymphoblastic Leukemia; Thrombosis; Bleeding; Hemostatic Disorder Interventions: Diagnostic Test: Coagulopathy parameters Sponsors: Karolinska University Hospital; Karolinska Institutet Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis
Conditions: Hepatocellular Carcinoma; Radiotherapy; Tislelizumab; Tumor Thrombosis Interventions: Radiation: Moderate-dose Hypofractionated Intensity-modulated Radiotherapy; Drug: Tislelizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Conditions: Venous Thromboembolic Disease; Pulmonary Embolism and Thrombosis; Deep Vein Thrombosis; Hospitalism Interventions: Other: EHR (electronic health record) alert; Other: No EHR (electronic health record) alert Sponsors: Scott C. Woller, MD; Janssen Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)
Conditions: Atrial Fibrillation; Cardioembolic Stroke; Left Atrial Appendage Thrombosis; Anticoagulant-induced Bleeding Sponsors: University Hospital, Brest Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Pregnancy and Postpartum Period Venous Thromboembolism and Simulation
Conditions: Simulation; Venous Thromboembolism Interventions: Other: Simulation application Sponsors: Saglik Bilimleri Universitesi Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Conditions: Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery Interventions: Drug: SHR-2004; Drug: Enoxaparin Sodium Injection; Rivaroxaban Tablets Sponsors: Beijing Suncadia Pharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
APPEND-CT Registry
Conditions: Stroke, Ischemic; Device Related Thrombosis; Atrial Fibrillation Interventions: Device: Watchman FLX left atrial appendage occlusion Sponsors: Aarhus University Hospital; Mayo Clinic; Boston Scientific Corporation Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis
Conditions: Embolism and Thrombosis; Anticoagulation Interventions: Procedure: Extended anticoagulation Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)
Conditions: Hepatocellular Carcinoma With PVTT Interventions: Drug: Tislelizumab; Drug: Lenvatinib Sponsors: Li Xiao Wei Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Promotion of Active Lifestyle in Thromboembolism Patients
Conditions: Pulmonary Thromboembolism Interventions: Other: Physical Activity Promotion; Other: Control Intervention Sponsors: Universidad de Granada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Blinded Randomized Controlled Trial of Artificial Intelligence Guided Detection of Intracardiac Thrombus
Conditions: Atrial Fibrillation Interventions: Other: Automated detection of the intracardiac thrombus through deep learning; Other: Electrophysiologist judgment of the intracardiac thrombus Sponsors: Shanghai Chest Hospital; Johnson& Johnson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Inflow Improve for Deep Vein thrombOsis With Ultrasound acceLerated thrombOlysis and Venoplasty
Conditions: Post-Thrombotic Syndrome of Both Legs Interventions: Other: ultrasound accelerated thrombolysis and venoplasty Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
Conditions: Glioma, Malignant Interventions: Drug: Rivaroxaban 10 MG; Drug: Placebo Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
